1-(5-bromo-2-pyridinyl)-4-methylpiperazine;2-chloro-10-[3-(trifluoromethyl)phenyl]pyrido[3,2-c][1,5]naphthyridin-9-one;2,5-dibromopyridine;10-(3-methylphenyl)-2-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]pyrido[3,2-c][1,5]naphthyridin-9-one;1-methylpiperazine;bis(1-methyl-4-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinyl]piperazine);palladium;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;tetrakis(triphenylphosphane)

C182H200B4Br3ClF3N21O10P4Pd — CID 159628220

IUPAC1-(5-bromo-2-pyridinyl)-4-methylpiperazine;2-chloro-10-[3-(trifluoromethyl)phenyl]pyrido[3,2-c][1,5]naphthyridin-9-one;2,5-dibromopyridine;10-(3-methylphenyl)-2-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]pyrido[3,2-c][1,5]naphthyridin-9-one;1-methylpiperazine;bis(1-methyl-4-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinyl]piperazine);palladium;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;tetrakis(triphenylphosphane)
SMILESBrc1ccc(Br)nc1.CC1(C)OB(B2OC(C)(C)C(C)(C)O2)OC1(C)C.CN1CCN(c2ccc(B3OC(C)(C)C(C)(C)O3)cn2)CC1.CN1CCN(c2ccc(B3OC(C)(C)C(C)(C)O3)cn2)CC1.CN1CCN(c2ccc(Br)cn2)CC1.CN1CCNCC1.Cc1cccc(-n2c(=O)ccc3cnc4ccc(-c5ccc(N6CCN(C)CC6)nc5)nc4c32)c1.O=c1ccc2cnc3ccc(Cl)nc3c2n1-c1cccc(C(F)(F)F)c1.[Pd].c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1
InChIInChI=1S/C28H26N6O.C18H9ClF3N3O.4C18H15P.2C16H26BN3O2.C12H24B2O4.C10H14BrN3.C5H3Br2N.C5H12N2.Pd/c1-19-4-3-5-22(16-19)34-26(35)11-7-21-18-29-24-9-8-23(31-27(24)28(21)34)20-6-10-25(30-17-20)33-14-12-32(2)13-15-33;19-14-6-5-13-16(24-14)17-10(9-23-13)4-7-15(26)25(17)12-3-1-2-11(8-12)18(20,21)22;4*1-4-10-16(11-5-1)19(17-12-6-2-7-13-17)18-14-8-3-9-15-18;2*1-15(2)16(3,4)22-17(21-15)13-6-7-14(18-12-13)20-10-8-19(5)9-11-20;1-9(2)10(3,4)16-13(15-9)14-17-11(5,6)12(7,8)18-14;1-13-4-6-14(7-5-13)10-3-2-9(11)8-12-10;6-4-1-2-5(7)8-3-4;1-7-4-2-6-3-5-7;/h3-11,16-18H,12-15H2,1-2H3;1-9H;4*1-15H;2*6-7,12H,8-11H2,1-5H3;1-8H3;2-3,8H,4-7H2,1H3;1-3H;6H,2-5H2,1H3;
InChIKeyMOTWTCLEPVJDQM-UHFFFAOYSA-N
MW3447.46 g/mol
LogP30.68
Rot. Bonds22

About 1-(5-bromo-2-pyridinyl)-4-methylpiperazine;2-chloro-10-[3-(trifluoromethyl)phenyl]pyrido[3,2-c][1,5]naphthyridin-9-one;2,5-dibromopyridine;10-(3-methylphenyl)-2-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]pyrido[3,2-c][1,5]naphthyridin-9-one;1-methylpiperazine;bis(1-methyl-4-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinyl]piperazine);palladium;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;tetrakis(triphenylphosphane)

1-(5-bromo-2-pyridinyl)-4-methylpiperazine;2-chloro-10-[3-(trifluoromethyl)phenyl]pyrido[3,2-c][1,5]naphthyridin-9-one;2,5-dibromopyridine;10-(3-methylphenyl)-2-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]pyrido[3,2-c][1,5]naphthyridin-9-one;1-methylpiperazine;bis(1-methyl-4-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinyl]piperazine);palladium;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;tetrakis(triphenylphosphane) (PubChem CID 159628220) has the molecular formula C182H200B4Br3ClF3N21O10P4Pd and a molecular weight of 3447.46 g/mol. Its IUPAC name is 1-(5-bromo-2-pyridinyl)-4-methylpiperazine;2-chloro-10-[3-(trifluoromethyl)phenyl]pyrido[3,2-c][1,5]naphthyridin-9-one;2,5-dibromopyridine;10-(3-methylphenyl)-2-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]pyrido[3,2-c][1,5]naphthyridin-9-one;1-methylpiperazine;bis(1-methyl-4-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinyl]piperazine);palladium;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;tetrakis(triphenylphosphane).

Molecular Properties

Compound Name1-(5-bromo-2-pyridinyl)-4-methylpiperazine;2-chloro-10-[3-(trifluoromethyl)phenyl]pyrido[3,2-c][1,5]naphthyridin-9-one;2,5-dibromopyridine;10-(3-methylphenyl)-2-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]pyrido[3,2-c][1,5]naphthyridin-9-one;1-methylpiperazine;bis(1-methyl-4-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinyl]piperazine);palladium;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;tetrakis(triphenylphosphane)
PubChem CID159628220
Molecular FormulaC182H200B4Br3ClF3N21O10P4Pd
Molecular Weight3447.46 g/mol
Exact Mass3442.13
IUPAC Name1-(5-bromo-2-pyridinyl)-4-methylpiperazine;2-chloro-10-[3-(trifluoromethyl)phenyl]pyrido[3,2-c][1,5]naphthyridin-9-one;2,5-dibromopyridine;10-(3-methylphenyl)-2-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]pyrido[3,2-c][1,5]naphthyridin-9-one;1-methylpiperazine;bis(1-methyl-4-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinyl]piperazine);palladium;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;tetrakis(triphenylphosphane)
SMILESBrc1ccc(Br)nc1.CC1(C)OB(B2OC(C)(C)C(C)(C)O2)OC1(C)C.CN1CCN(c2ccc(B3OC(C)(C)C(C)(C)O3)cn2)CC1.CN1CCN(c2ccc(B3OC(C)(C)C(C)(C)O3)cn2)CC1.CN1CCN(c2ccc(Br)cn2)CC1.CN1CCNCC1.Cc1cccc(-n2c(=O)ccc3cnc4ccc(-c5ccc(N6CCN(C)CC6)nc5)nc4c32)c1.O=c1ccc2cnc3ccc(Cl)nc3c2n1-c1cccc(C(F)(F)F)c1.[Pd].c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1
InChIInChI=1S/C28H26N6O.C18H9ClF3N3O.4C18H15P.2C16H26BN3O2.C12H24B2O4.C10H14BrN3.C5H3Br2N.C5H12N2.Pd/c1-19-4-3-5-22(16-19)34-26(35)11-7-21-18-29-24-9-8-23(31-27(24)28(21)34)20-6-10-25(30-17-20)33-14-12-32(2)13-15-33;19-14-6-5-13-16(24-14)17-10(9-23-13)4-7-15(26)25(17)12-3-1-2-11(8-12)18(20,21)22;4*1-4-10-16(11-5-1)19(17-12-6-2-7-13-17)18-14-8-3-9-15-18;2*1-15(2)16(3,4)22-17(21-15)13-6-7-14(18-12-13)20-10-8-19(5)9-11-20;1-9(2)10(3,4)16-13(15-9)14-17-11(5,6)12(7,8)18-14;1-13-4-6-14(7-5-13)10-3-2-9(11)8-12-10;6-4-1-2-5(7)8-3-4;1-7-4-2-6-3-5-7;/h3-11,16-18H,12-15H2,1-2H3;1-9H;4*1-15H;2*6-7,12H,8-11H2,1-5H3;1-8H3;2-3,8H,4-7H2,1H3;1-3H;6H,2-5H2,1H3;
InChIKeyMOTWTCLEPVJDQM-UHFFFAOYSA-N
XLogP30.68
TPSA275.04 Ų
H-Bond Donors1
H-Bond Acceptors31
Rotatable Bonds22
Heavy Atoms229
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5003447.46
LogP ≤ 530.68
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1031

Computed Properties (RDKit)

Structural Alerts{'alert_name': '2-halo_pyridine', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'phosphor', 'substructure': 'N/A'}, {'alert_name': 'Polycyclic_aromatic_hydrocarbon_3', 'substructure': 'N/A'}

Analyze 1-(5-bromo-2-pyridinyl)-4-methylpiperazine;2-chloro-10-[3-(trifluoromethyl)phenyl]pyrido[3,2-c][1,5]naphthyridin-9-one;2,5-dibromopyridine;10-(3-methylphenyl)-2-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]pyrido[3,2-c][1,5]naphthyridin-9-one;1-methylpiperazine;bis(1-methyl-4-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinyl]piperazine);palladium;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;tetrakis(triphenylphosphane) with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

9-chloro-3-methyl-1-[3-(trifluoromethyl)phenyl]-4H-pyrimido[5,4-c][1,5]naphthyridin-2-one;methane;3-methyl-9-[6-(2-oxopropyl)-3-pyridinyl]-1-[3-(trifluoromethyl)phenyl]-4H-pyrimido[5,4-c][1,5]naphthyridin-2-one;palladium;5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine;N-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinyl]acetamide;tetrakis(triphenylphosphane)
CID 158219000
2-chloro-10-[3-(trifluoromethyl)phenyl]pyrido[3,2-c][1,5]naphthyridin-9-one;2-(7H-cyclopenta[b]pyridin-3-yl)-10-[3-(trifluoromethyl)phenyl]pyrido[3,2-c][1,5]naphthyridin-9-one;palladium;5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-b]pyridine;tetrakis(triphenylphosphane)
CID 158233250
2-Chloro-10-[3-(trifluoromethyl)phenyl]pyrido[3,2-c][1,5]naphthyridin-9-one;10-(3-methylphenyl)-2-(6-pyrrolidin-1-yl-3-pyridinyl)pyrido[3,2-c][1,5]naphthyridin-9-one;palladium;2-pyrrolidin-1-yl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine;tetrakis(triphenylphosphane)
CID 158368156
sodium;5-bromo-2-pyrazol-1-ylpyridine;2-chloro-10-[3-(trifluoromethyl)phenyl]pyrido[3,2-c][1,5]naphthyridin-9-one;deuterio(fluoro)methane;2,5-dibromopyridine;hydride;10-(3-methylphenyl)-2-(6-pyrazol-1-yl-3-pyridinyl)pyrido[3,2-c][1,5]naphthyridin-9-one;palladium;1H-pyrazole;2-pyrazol-1-yl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;tetrakis(triphenylphosphane)
CID 158371065
5-Bromo-3-methylpyridine-2-carbonitrile;2-chloro-10-[3-(trifluoromethyl)phenyl]pyrido[3,2-c][1,5]naphthyridin-9-one;copper(1+);deuterio(fluoro)methane;2,5-dibromo-3-methylpyridine;2-(6-isocyano-5-methyl-3-pyridinyl)-10-[3-(trifluoromethyl)phenyl]pyrido[3,2-c][1,5]naphthyridin-9-one;3-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine-2-carbonitrile;palladium;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;tetrakis(triphenylphosphane);cyanide
CID 159188341
9-(2-aminopyrimidin-5-yl)-3-methyl-1-[3-(trifluoromethyl)phenyl]-4H-pyrimido[5,4-c][1,5]naphthyridin-2-one;9-chloro-3-methyl-1-[3-(trifluoromethyl)phenyl]-4H-pyrimido[5,4-c][1,5]naphthyridin-2-one;palladium;5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine;tetrakis(triphenylphosphane)
CID 160359429
2-chloro-10-[3-(trifluoromethyl)phenyl]pyrido[3,2-c][1,5]naphthyridin-9-one;2-[6-(2-oxopropyl)-3-pyridinyl]-10-[3-(trifluoromethyl)phenyl]pyrido[3,2-c][1,5]naphthyridin-9-one;palladium;5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine;N-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinyl]acetamide;tetrakis(triphenylphosphane)
CID 160507580
3-Bromo-5-methylpyridine;2-chloro-10-[3-(trifluoromethyl)phenyl]pyrido[3,2-c][1,5]naphthyridin-9-one;2-(5-methyl-3-pyridinyl)-10-[3-(trifluoromethyl)phenyl]pyrido[3,2-c][1,5]naphthyridin-9-one;palladium;3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5-(trifluoromethyl)pyridine;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;tetrakis(triphenylphosphane)
CID 161292926
2-Chloro-10-[3-(trifluoromethyl)phenyl]pyrido[3,2-c][1,5]naphthyridin-9-one;2-(6-isocyano-3-pyridinyl)-10-[3-(trifluoromethyl)phenyl]pyrido[3,2-c][1,5]naphthyridin-9-one;2-isocyano-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine;palladium;tetrakis(triphenylphosphane)
CID 161672400

Frequently Asked Questions

What is the IUPAC name of 1-(5-bromo-2-pyridinyl)-4-methylpiperazine;2-chloro-10-[3-(trifluoromethyl)phenyl]pyrido[3,2-c][1,5]naphthyridin-9-one;2,5-dibromopyridine;10-(3-methylphenyl)-2-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]pyrido[3,2-c][1,5]naphthyridin-9-one;1-methylpiperazine;bis(1-methyl-4-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinyl]piperazine);palladium;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;tetrakis(triphenylphosphane)?
The IUPAC name of 1-(5-bromo-2-pyridinyl)-4-methylpiperazine;2-chloro-10-[3-(trifluoromethyl)phenyl]pyrido[3,2-c][1,5]naphthyridin-9-one;2,5-dibromopyridine;10-(3-methylphenyl)-2-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]pyrido[3,2-c][1,5]naphthyridin-9-one;1-methylpiperazine;bis(1-methyl-4-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinyl]piperazine);palladium;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;tetrakis(triphenylphosphane) (CID 159628220) is 1-(5-bromo-2-pyridinyl)-4-methylpiperazine;2-chloro-10-[3-(trifluoromethyl)phenyl]pyrido[3,2-c][1,5]naphthyridin-9-one;2,5-dibromopyridine;10-(3-methylphenyl)-2-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]pyrido[3,2-c][1,5]naphthyridin-9-one;1-methylpiperazine;bis(1-methyl-4-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinyl]piperazine);palladium;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;tetrakis(triphenylphosphane).
What is the SMILES notation for 1-(5-bromo-2-pyridinyl)-4-methylpiperazine;2-chloro-10-[3-(trifluoromethyl)phenyl]pyrido[3,2-c][1,5]naphthyridin-9-one;2,5-dibromopyridine;10-(3-methylphenyl)-2-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]pyrido[3,2-c][1,5]naphthyridin-9-one;1-methylpiperazine;bis(1-methyl-4-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinyl]piperazine);palladium;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;tetrakis(triphenylphosphane)?
The canonical SMILES for 1-(5-bromo-2-pyridinyl)-4-methylpiperazine;2-chloro-10-[3-(trifluoromethyl)phenyl]pyrido[3,2-c][1,5]naphthyridin-9-one;2,5-dibromopyridine;10-(3-methylphenyl)-2-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]pyrido[3,2-c][1,5]naphthyridin-9-one;1-methylpiperazine;bis(1-methyl-4-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinyl]piperazine);palladium;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;tetrakis(triphenylphosphane) is Brc1ccc(Br)nc1.CC1(C)OB(B2OC(C)(C)C(C)(C)O2)OC1(C)C.CN1CCN(c2ccc(B3OC(C)(C)C(C)(C)O3)cn2)CC1.CN1CCN(c2ccc(B3OC(C)(C)C(C)(C)O3)cn2)CC1.CN1CCN(c2ccc(Br)cn2)CC1.CN1CCNCC1.Cc1cccc(-n2c(=O)ccc3cnc4ccc(-c5ccc(N6CCN(C)CC6)nc5)nc4c32)c1.O=c1ccc2cnc3ccc(Cl)nc3c2n1-c1cccc(C(F)(F)F)c1.[Pd].c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1.
What is the InChIKey of 1-(5-bromo-2-pyridinyl)-4-methylpiperazine;2-chloro-10-[3-(trifluoromethyl)phenyl]pyrido[3,2-c][1,5]naphthyridin-9-one;2,5-dibromopyridine;10-(3-methylphenyl)-2-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]pyrido[3,2-c][1,5]naphthyridin-9-one;1-methylpiperazine;bis(1-methyl-4-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinyl]piperazine);palladium;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;tetrakis(triphenylphosphane)?
The InChIKey is MOTWTCLEPVJDQM-UHFFFAOYSA-N. The full InChI is InChI=1S/C28H26N6O.C18H9ClF3N3O.4C18H15P.2C16H26BN3O2.C12H24B2O4.C10H14BrN3.C5H3Br2N.C5H12N2.Pd/c1-19-4-3-5-22(16-19)34-26(35)11-7-21-18-29-24-9-8-23(31-27(24)28(21)34)20-6-10-25(30-17-20)33-14-12-32(2)13-15-33;19-14-6-5-13-16(24-14)17-10(9-23-13)4-7-15(26)25(17)12-3-1-2-11(8-12)18(20,21)22;4*1-4-10-16(11-5-1)19(17-12-6-2-7-13-17)18-14-8-3-9-15-18;2*1-15(2)16(3,4)22-17(21-15)13-6-7-14(18-12-13)20-10-8-19(5)9-11-20;1-9(2)10(3,4)16-13(15-9)14-17-11(5,6)12(7,8)18-14;1-13-4-6-14(7-5-13)10-3-2-9(11)8-12-10;6-4-1-2-5(7)8-3-4;1-7-4-2-6-3-5-7;/h3-11,16-18H,12-15H2,1-2H3;1-9H;4*1-15H;2*6-7,12H,8-11H2,1-5H3;1-8H3;2-3,8H,4-7H2,1H3;1-3H;6H,2-5H2,1H3;.
What are the key properties of 1-(5-bromo-2-pyridinyl)-4-methylpiperazine;2-chloro-10-[3-(trifluoromethyl)phenyl]pyrido[3,2-c][1,5]naphthyridin-9-one;2,5-dibromopyridine;10-(3-methylphenyl)-2-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]pyrido[3,2-c][1,5]naphthyridin-9-one;1-methylpiperazine;bis(1-methyl-4-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinyl]piperazine);palladium;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;tetrakis(triphenylphosphane)?
1-(5-bromo-2-pyridinyl)-4-methylpiperazine;2-chloro-10-[3-(trifluoromethyl)phenyl]pyrido[3,2-c][1,5]naphthyridin-9-one;2,5-dibromopyridine;10-(3-methylphenyl)-2-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]pyrido[3,2-c][1,5]naphthyridin-9-one;1-methylpiperazine;bis(1-methyl-4-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinyl]piperazine);palladium;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;tetrakis(triphenylphosphane) has a molecular weight of 3447.46 g/mol, XLogP of 30.68, 22 rotatable bonds, 1 hydrogen bond donors, and 31 hydrogen bond acceptors.
Where does this data come from?
All data for 1-(5-bromo-2-pyridinyl)-4-methylpiperazine;2-chloro-10-[3-(trifluoromethyl)phenyl]pyrido[3,2-c][1,5]naphthyridin-9-one;2,5-dibromopyridine;10-(3-methylphenyl)-2-[6-(4-methylpiperazin-1-yl)-3-pyridinyl]pyrido[3,2-c][1,5]naphthyridin-9-one;1-methylpiperazine;bis(1-methyl-4-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinyl]piperazine);palladium;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;tetrakis(triphenylphosphane) is sourced from PubChem (CID 159628220), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).